Cargando…
Construction of a novel quinoxaline as a new class of Nrf2 activator
BACKGROUND: The transcription factor Nuclear factor erythroid-2-related factor 2 (NRF2) and its principal repressive regulator, Kelch-like ECH-associated protein 1 (KEAP1), are perilous in the regulation of inflammation, as well as maintenance of homeostasis. Thus, NRF2 activation is involved in cyt...
Autores principales: | Kandasamy, Murugesh, Mak, Kit-Kay, Devadoss, Thangaraj, Thanikachalam, Punniyakoti Veeraveedu, Sakirolla, Raghavendra, Choudhury, Hira, Pichika, Mallikarjuna Rao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760105/ https://www.ncbi.nlm.nih.gov/pubmed/31572984 http://dx.doi.org/10.1186/s13065-019-0633-4 |
Ejemplares similares
-
Synthesis of New Shogaol Analogues as NRF2 Activators and Evaluation of Their Anti-Inflammatory Activity, Modes of Action and Metabolic Stability
por: Mak, Kit-Kay, et al.
Publicado: (2023) -
Synthesis and Anti‐Inflammatory Activity of 2‐Amino‐4,5,6,7‐tetrahydrobenzo[b]thiophene‐Derived NRF2 Activators
por: Mak, Kit‐Kay, et al.
Publicado: (2022) -
Anti-Inflammatory Effects of Auranamide and Patriscabratine—Mechanisms and In Silico Studies
por: Mak, Kit-Kay, et al.
Publicado: (2022) -
In-vitro evaluation of the effectiveness of polyphenols based strawberry extracts for dental bleaching
por: Kohli, Shivani, et al.
Publicado: (2023) -
An overview on medicinal perspective of thiazolidine-2,4-dione: A remarkable scaffold in the treatment of type 2 diabetes
por: Bansal, Garima, et al.
Publicado: (2020)